## Abstract ## Background. We describe the development and validation of the Vanderbilt Head and Neck Symptom Survey (VHNSS), which was designed to screen for tumor‐ and treatment‐specific symptoms in patients with head and neck cancer undergoing concurrent chemoradiation (CCR). ## Methods. Usin
Measuring head and neck cancer symptom burden: The development and validation of the M. D. Anderson symptom inventory, head and neck module
✍ Scribed by David I. Rosenthal; Tito R. Mendoza; Mark S. Chambers; Joshua A. Asper; Ibrahima Gning; Merrill S. Kies; Randal S. Weber; Jan S. Lewin; Adam S. Garden; K. Kian Ang; Xin S. Wang; Charles S. Cleeland
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 181 KB
- Volume
- 29
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background.
The aim of this study was to develop and validate a symptom inventory for patients with head and neck cancer and to assess the occurrence and severity of symptoms, the overall symptom burden, and the interference the symptoms cause in daily life.
Methods.
Items were generated from a comprehensive literature review, our prior work, and focus groups with head and neck cancer patients, symptom researchers, and a multidisciplinary group of head and neck cancer health care workers. We selected 11 provisional head and neck cancer‐specific items for addition to the core M. D. Anderson Symptom Inventory (MDASI), and conducted a cross‐sectional validation study among patients with head and neck cancer.
Results.
Construct validity was established using principal axis factoring with direct oblimin rotation, and tests of concurrent and known‐groups validity were conducted. Two items were dropped because of low severity scores and low frequency of complaint, leaving 9 final head and neck cancer‐specific items. The coefficient α reliabilities were 0.88, 0.83, and 0.92 for the 13 core MDASI items, the 9 head and neck cancer‐specific items, and the 6 interference items, respectively. The most prevalent severe symptoms were problems with mucus, mouth/throat sores, tasting food, difficulty with chewing or swallowing, dry mouth, pain, and fatigue.
Conclusions.
The M. D. Anderson Symptom Inventory‐Head and Neck (MDASI‐HN) is a reliable and valid instrument to measure head and neck cancer symptom burden, and the interference symptoms cause in the major aspects of a patient's daily life. A subset of specifically distressing symptoms was identified, many of which are not included in commonly used head and neck cancer quality of life instruments. © 2007 Wiley Periodicals, Inc. Head Neck 2007
📜 SIMILAR VOLUMES
## Abstract ## Background. Our aim was to review our experience with liposarcoma of the head and neck region. ## Methods. This is a retrospective case series at a comprehensive cancer center (1945–2005). ## Results. Of 30 patients, 10 (33%) were initially misdiagnosed. Local recurrences were c
## Background: Our objective was to develop and examine the psychometric properties of the satisfaction with cancer information profile (scip), a new measure designed to assess the extent to which patients with head and neck cancer (hnc) are satisfied with information received about their treatment
Background. Serum liver function tests (LFTs) are used in the initial evaluation of patients with head and neck squamous cell carcinoma (SCC) to evaluate hepatic function and to screen for liver metastases. Methods. One hundred forty patients initially seen with SCC between 1988 and 1991 were follo
## Abstract ## Background The aim of this study was to develop and validate the first ever speech‐specific perceptual speech‐evaluation tool for patients with head and neck cancer. ## Methods Five speech parameters (intelligibility, articulation, speech rate, nasality, and asthenia) and overall